Drug Maker to Stop Selling Medicine for Multiple Sclerosis in August

(Beijing) – German drugs and pesticides maker Bayer AG will stop selling a type of medicine to treat multiple sclerosis in mid-2016 due to "supply problems," a government-backed charity warned.

The drug maker confirmed that it will stop selling the drug, known by its trade name Betaferon, in the domestic market in August. It was tight-lipped about why it plans to cut supplies in China.